GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/15/2022 8:21:18 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $10,543,000 -34.3% | Assets $99,366,000 | EPS $0.08 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/16/2022 4:30:00 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $10,425,000 -69.5% | Assets $96,378,000 | ||
| La Jolla Pharmaceutical Co (LJPC) | 5/16/2022 4:19:18 PM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $10,425,000 -69.5% | Assets $96,378,000 | Export Earnings Model | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/2/2022 5:16:35 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Rev: $75,720,000 +126.6% | Assets $101,230,000 | EPS $0.58 | |
| La Jolla Pharmaceutical Co (LJPC) | 3/9/2022 8:16:18 AM | View | Financials | Earnings | WIRE | Y 2021 | Rev $12,210,000 +11.5% | Assets $101,230,000 | EPS $0.12 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/9/2022 8:14:16 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $75,720,000 +126.6% | Assets $101,230,000 | EPS $0.58 | |
| La Jolla Pharmaceutical Co (LJPC) | 11/4/2021 8:49:27 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $13,314,000 +46.8% | Assets $100,294,000 | EPS -$0.08 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/4/2021 8:45:29 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $13,314,000 +46.8% | Assets $100,294,000 | EPS -$0.08 | |
| La Jolla Pharmaceutical Co (LJPC) | 8/5/2021 8:35:28 AM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $16,059,000 +176.6% | Assets $100,008,000 | EPS $0.11 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/5/2021 8:12:46 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $16,059,000 +176.6% | Assets $100,008,000 | EPS $0.11 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 6/4/2021 7:07:06 AM | View | Proxy | SEC | Y 2020 | ||||||
| La Jolla Pharmaceutical Co (LJPC) | 5/7/2021 8:49:19 AM | View | Financials | Earnings | WIRE | 1Q 2021 | Rev $34,137,000 +349.7% | Assets $89,589,000 | EPS $0.42 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/7/2021 8:43:08 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $34,137,000 +349.7% | Assets $89,589,000 | EPS $0.42 | |
| La Jolla Pharmaceutical Co (LJPC) | 3/8/2021 8:56:09 AM | View | Financials | Earnings | WIRE | Y 2020 | Rev $10,951,000 +51.0% | Assets $72,243,000 | EPS -$0.12 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/8/2021 8:44:08 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $33,419,000 +45.0% | Assets $72,243,000 | EPS -$1.44 | |
| La Jolla Pharmaceutical Co (LJPC) | 11/9/2020 5:36:26 PM | View | Financials | Earnings | WIRE | 3Q 2020 | Rev $9,072,000 +59.0% | Assets $80,720,000 | EPS -$0.43 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/9/2020 5:03:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $9,072,000 +59.0% | Assets $80,720,000 | EPS -$0.43 | |
| La Jolla Pharmaceutical Co (LJPC) | 8/6/2020 8:31:54 AM | View | Financials | Earnings | WIRE | 2Q 2020 | Rev $5,805,000 +1.8% | Assets $107,395,000 | EPS -$0.57 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/6/2020 7:54:18 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $5,805,000 +1.8% | Assets $107,395,000 | EPS -$0.57 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/4/2020 8:22:44 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $7,591,000 +72.7% | Assets $118,207,000 | EPS -$0.32 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/29/2020 5:21:29 PM | View | Proxy | SEC | Y 2019 | ||||||
| La Jolla Pharmaceutical Co (LJPC) | 3/2/2020 8:31:43 AM | View | Financials | Earnings | WIRE | Y 2019 | Rev $7,250,000 +71.6% | Assets $132,247,000 | EPS -$0.93 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/2/2020 8:24:45 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $23,054,000 +128.3% | Assets $132,247,000 | EPS -$4.30 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 1/10/2020 8:58:36 AM | View | Financials | Earnings (Prelim) | SEC | Y 2019 | Export Earnings Model | ||||
| La Jolla Pharmaceutical Co (LJPC) | 11/12/2019 4:48:12 PM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $5,706,000 +64.4% | Assets $149,139,000 | EPS -$1.08 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/12/2019 4:24:14 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $5,706,000 +64.4% | Assets $149,139,000 | EPS -$1.08 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 9/18/2019 4:19:34 PM | View | Proxy | SEC | Y 2018 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/7/2019 8:30:53 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $5,703,000 +258.0% | Assets $169,894,000 | EPS -$1.12 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/1/2019 8:33:42 AM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $5,703,000 +258.0% | Assets $169,894,000 | EPS -$1.12 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/6/2019 4:27:12 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $4,395,000 +443.3% | Assets $187,829,000 | EPS -$1.17 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/6/2019 4:20:32 PM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $4,395,000 +443.3% | Assets $187,829,000 | EPS -$1.17 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/4/2019 4:56:05 PM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $10,098,000 | Assets $204,292,000 | EPS -$2.29 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/4/2019 4:08:01 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $4,226,000 | Assets $204,292,000 | EPS $3.86 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 1/7/2019 9:03:28 AM | View | Financials | Earnings (Prelim) | SEC | Y 2018 | Export Earnings Model | ||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 10/24/2018 4:14:48 PM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $3,470,000 | Assets $237,070,000 | EPS -$1.93 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 10/24/2018 4:09:04 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $3,470,000 | Assets $237,070,000 | EPS -$1.93 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/22/2018 4:39:08 PM | View | Proxy | SEC | Y 2017 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/8/2018 4:35:59 PM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $1,593,000 | Assets $273,140,000 | EPS -$2.02 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/8/2018 4:08:30 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $1,593,000 | Assets $273,140,000 | EPS -$2.02 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/14/2018 5:22:02 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $809,000 | Assets $186,901,000 | EPS -$2.22 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/10/2018 5:00:14 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $809,000 | Assets $186,901,000 | EPS -$2.22 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 2/22/2018 5:16:42 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $119,539,000 | EPS -$5.41 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 10/27/2017 5:48:39 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $0 | Assets $130,057,000 | EPS -$1.19 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 10/26/2017 5:26:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $130,057,000 | EPS -$1.19 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/28/2017 6:48:13 PM | View | Proxy | SEC | Y 2016 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/27/2017 4:58:18 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $0 | Assets $148,587,000 | EPS -$1.21 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/27/2017 4:33:26 PM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $148,587,000 | EPS -$1.21 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/1/2017 4:04:28 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $0 | Assets $168,007,000 | EPS -$1.26 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/27/2017 4:14:58 PM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $168,007,000 | EPS -$1.26 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 2/23/2017 5:05:32 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $85,000 -79.3% | Assets $70,795,000 | EPS -$1.44 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 2/23/2017 4:14:02 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $616,000 -70.9% | Assets $70,795,000 | EPS -$4.54 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/9/2016 4:38:21 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $88,000 -93.2% | Assets $89,521,000 | EPS -$1.23 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/3/2016 4:06:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $88,000 -93.2% | Assets $89,521,000 | EPS -$1.23 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/12/2016 4:18:37 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $506,000 | Assets $104,774,000 | EPS -$0.90 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/8/2016 4:07:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $506,000 | Assets $104,774,000 | EPS -$0.90 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/22/2016 4:48:46 PM | View | Proxy | SEC | Y 2015 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/11/2016 8:29:03 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $468,000 | Assets $117,007,000 | EPS -$0.96 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/6/2016 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $468,000 | Assets $117,007,000 | EPS -$0.96 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/2/2016 4:15:21 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $410,000 | Assets $129,347,000 | EPS -$0.69 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 2/25/2016 4:20:03 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $2,114,000 | Assets $129,347,000 | EPS -$2.68 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/12/2015 4:45:36 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $1,294,000 | Assets $137,944,000 | EPS -$0.70 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/6/2015 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $1,294,000 | Assets $137,944,000 | EPS -$0.70 | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/11/2015 6:14:31 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $0 | Assets $38,729,000 | EPS -$0.70 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/6/2015 4:42:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $38,729,000 | EPS -$0.70 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/17/2015 6:05:49 PM | View | Proxy | SEC | Y 2014 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/5/2015 4:58:04 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $0 | Assets $45,536,000 | EPS -$0.59 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/29/2015 4:26:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $45,536,000 | EPS -$0.59 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/18/2015 5:20:02 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $0 | Assets $50,536,000 | EPS -$0.45 | Export Earnings Model | |
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/16/2015 4:24:09 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $50,536,000 | EPS -$2.00 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/18/2014 4:54:27 PM | View | Financials | Earnings | SEC | 3Q 2014 | Assets $54,435,000 | Export Earnings Model | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/12/2014 4:03:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $54,435,000 | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/14/2014 4:37:40 PM | View | Financials | Earnings | SEC | 2Q 2014 | Assets $4,162,000 | Export Earnings Model | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/14/2014 4:16:18 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $4,162,000 | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/29/2014 4:26:28 PM | View | Proxy | SEC | Y 2013 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/25/2014 4:19:54 PM | View | Financials | Earnings | SEC | 2Q 2014 | Assets $4,162,000 | Export Earnings Model | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/30/2014 5:12:35 PM | View | Financials | Earnings | SEC | 1Q 2014 | Assets $6,129,000 | Export Earnings Model | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/30/2014 4:35:35 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $6,129,000 | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/4/2014 9:39:25 PM | View | Financials | Earnings | SEC | 1Q 2014 | Assets $6,129,000 | Export Earnings Model | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/31/2014 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Assets $8,747,000 | EPS -$12.16 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/18/2013 4:25:47 PM | View | Proxy | SEC | Y 2012 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/12/2013 5:05:04 PM | View | Financials | Earnings | SEC | 3Q 2013 | Assets $10,821,000 | EPS -$5.45 | Export Earnings Model | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/8/2013 4:21:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $10,821,000 | EPS -$5.45 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/25/2013 8:01:59 AM | View | Financials | Earnings | SEC | 2Q 2013 | Assets $1,983,000 | EPS -$6.77 | Export Earnings Model | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 7/19/2013 5:22:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $1,983,000 | EPS -$6.77 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/15/2013 4:09:36 PM | View | Financials | Earnings | SEC | 1Q 2013 | Assets $2,813,000 | EPS -$0.25 | Export Earnings Model | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/13/2013 4:25:34 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Assets $2,813,000 | EPS -$0.25 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/13/2013 2:53:38 PM | View | Proxy | SEC | Y 2012 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/4/2013 5:11:24 PM | View | Financials | Earnings | SEC | Y 2012 | Assets $3,430,000 | EPS -$41.22 | Export Earnings Model | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/1/2013 5:17:16 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Assets $3,430,000 | EPS -$41.77 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/9/2012 4:06:10 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Assets $3,403,000 | EPS -$0.18 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 8/10/2012 4:01:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Assets $3,903,000 | EPS -$0.67 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 5/21/2012 4:58:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Assets $4,431,000 | |||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/23/2012 4:15:25 PM | View | Proxy | SEC | Y 2011 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 4/16/2012 5:31:10 PM | View | Proxy | SEC | Y 2011 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 3/30/2012 5:19:07 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Assets $5,100,000 | EPS -$31.59 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 11/14/2011 6:06:33 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Assets $5,511,000 | EPS $0.28 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 9/12/2011 3:44:21 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Assets $5,811,000 | EPS $0.01 | ||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 6/25/2010 5:28:55 PM | View | Proxy | SEC | Y 2009 | ||||||
| LA JOLLA PHARMACEUTICAL CO (LJPC) | 10/1/2009 6:01:00 AM | View | Proxy | SEC | Y 2008 |